Patients with lower expression of αSMA within the TME of solid tumors, such as in PDAC, HNSCC, and CRC [63,64], tend to have worse prognosis, further supporting the interpretation that αSMA+ CAFs restrict tumor growth. Here, ACTA1 is linked to head and neck squamous cell carcinoma.